Brucella Dysregulates Monocytes and Inhibits Macrophage Polarization through LC3-Dependent Autophagy by Wang, Yang et al.
June 2017 | Volume 8 | Article 6911
Original research
published: 12 June 2017
doi: 10.3389/fimmu.2017.00691
Frontiers in Immunology | www.frontiersin.org
Edited by: 
Juarez Antonio Simões Quaresma, 
Federal University of Pará, Brazil
Reviewed by: 
Victor Costa Castro-Alves, 
University of São Paulo, Brazil  
Carol Geralyn Chitko-McKown, 
U.S. Meat Animal Research Center 
(ARS-USDA), United States
*Correspondence:
Wanguo Bao 
wanguobao62230@126.com; 
Zhengkun Tu 
tuzhengkun@hotmail.com
†These authors have contributed 
equally to this work.
Specialty section: 
This article was submitted 
to Microbial Immunology, 
a section of the journal 
Frontiers in Immunology
Received: 31 March 2017
Accepted: 29 May 2017
Published: 12 June 2017
Citation: 
Wang Y, Li Y, Li H, Song H, Zhai N, 
Lou L, Wang F, Zhang K, Bao W, 
Jin X, Su L and Tu Z (2017) Brucella 
Dysregulates Monocytes and 
Inhibits Macrophage 
Polarization through LC3- 
Dependent Autophagy. 
Front. Immunol. 8:691. 
doi: 10.3389/fimmu.2017.00691
Brucella Dysregulates Monocytes 
and inhibits Macrophage Polarization 
through lc3-Dependent autophagy
Yang Wang1,2†, Yuxiang Li 2†, Haijun Li 1†, Hongxiao Song 1, Naicui Zhai 1, Lixin Lou 2,  
Feng Wang 2, Kaiyu Zhang 2, Wanguo Bao 2*, Xia Jin 3, Lishan Su 1,4 and Zhengkun Tu 1,2*
1 Institute of Translational Medicine, The First Hospital of Jilin University, Changchun, China, 2 Department of Infectious 
Diseases, The First Hospital of Jilin University, Changchun, China, 3 CAS Key Laboratory of Molecular Virology and 
Immunology, Institute Pasteur of Shanghai, Chinese Academy of Sciences, Shanghai, China, 4 Lineberger Comprehensive 
Cancer Center, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States
Brucellosis is caused by infection with Brucella species and exhibits diverse clinical 
manifestations in infected humans. Monocytes and macrophages are not only the first 
line of defense against Brucella infection but also a main reservoir for Brucella. In the 
present study, we examined the effects of Brucella infection on human peripheral mono-
cytes and monocyte-derived polarized macrophages. We showed that Brucella infection 
led to an increase in the proportion of CD14++CD16− monocytes and the expression of 
the autophagy-related protein LC3B, and the effects of Brucella-induced monocytes are 
inhibited after 6 weeks of antibiotic treatment. Additionally, the production of IL-1β, IL-6, 
IL-10, and TNF-α from monocytes in patients with brucellosis was suppressed through 
the LC3-dependent autophagy pathway during Brucella infection. Moreover, Brucella 
infection inhibited macrophage polarization. Consistently, the addition of 3-MA, an inhib-
itor of LC3-related autophagy, partially restored macrophage polarization. Intriguingly, 
we also found that the upregulation of LC3B expression by rapamycin and heat-killed 
Brucella in vitro inhibits M2 macrophage polarization, which can be reversed partially 
by 3-MA. Taken together, these findings reveal that Brucella dysregulates monocyte 
and macrophage polarization through LC3-dependent autophagy. Thus, targeting this 
pathway may lead to the development of new therapeutics against Brucellosis.
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inTrODUcTiOn
Brucellosis is a zoonotic infection caused by Brucella, a genus of Gram-negative bacteria that 
mostly infects animals including sheep, cattle, goats, pigs, and dogs. However, several Brucella 
species such as Brucella abortus, Brucella melitensis, B. suis, and B. canis can also infect humans (1). 
Brucellosis is one of the most common zoonotic bacterial infections worldwide, with over 500,000 
new human cases annually and a prevalence rate exceeding 10/100,000 in some countries (2).
Brucella infection triggers a complex host response that involves both innate and adaptive 
immunity. More and more evidences show that host innate immune responses play critical roles 
in the control of Brucella infection (3). Brucella invades and replicates within monocytes and 
macrophages. To survive the hostile intracellular environment, Brucella uses several strategies (4). 
The lipopolysaccharide (LPS) within the Brucella cell outer membrane contains a special lipid A 
Table 1 | Demographics and clinical characteristics of patients with brucellosis 
and healthy controls.
brucellosis 
patients
health  
controls
t-test
n 25 15
Male/female 15/10 8/7
Age (mean ± SD) 42.9 ± 18.1 31.8 ± 8.66 ns
Fever 98% 0%
Arthralgia 50% 0%
CNS 4% 0%
CRP (mean ± SD) 45.53 ± 22.14 1.93 ± 0.2815 P < 0.001
ESR (mean ± SD) 40.65 ± 17.45 7.75 ± 0.9435 P < 0.001
AST (mean ± SD) 38.94 ± 22.80 20.6 ± 1.545 P < 0.001
ALT (mean ± SD) 37.80 ± 23.01 16.7 ± 1.328 P < 0.001
Positive rose bengal agglutin 100% 0%
Positive serum agglutination 100% 0%
PCR test 100% 0%
CNS, central nervous system; CRP, C-reactive protein; ESR, erythrocyte sedimentation 
rate; AST, aspartate aminotransferase; ALT, alanine aminotransferase; PCR, 
polymerase chain reaction. P values of <0.05 were considered statistically significant. 
ns, not significant.
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that assists the evasion from the host immune system during the 
early stages of infection (5). The toll-like receptors (TLRs) TLR-
2, TLR-4, and TLR-9 are involved in the recognition of Brucella 
infection. TLR-2 is activated by lipidated outer membrane pro-
teins (L-Omp16 and L-Omp19); TLR-4 is activated by Brucella 
unlipidated outer membrane proteins (U-Omp16) and LPS; and 
TLR-9 is activated by Brucella DNA (6). TLR activation leads to 
intracellular signaling via MyD88 and IRAK-4 resulting in the 
activation of NF-κB and MAPKs and consequent production of 
inflammatory cytokines (7). Cytosolic sensors such as NOD1 and 
NOD2 are also involved in the recognition of Brucella DNA (6).
After entering mammalian cells, B. abortus resides within a 
membrane-bound compartment, the Brucella-containing vacu-
ole, which is covered from an endoplasmic reticulum derived repli-
cative organelle under the control of the bacterium (8, 9). Brucella 
escapes from immune surveillance and establishes infection 
through (a) restriction of fusion between Brucella-containing 
vac uoles and lysosomal compartments to avoid degradation, 
(b) inhibition of apoptosis of infected mononuclear cells to extend 
its replication time, (c) prevention of dendritic cell maturation 
and thus the efficiency of antigen presentation, and (d) restriction 
of T cell activation (10). Brucella may also exploit the auto phagic 
machinery to establish a favorable intracellular environment 
for its replication (8, 9).
Autophagy is a natural housekeeping mechanism through 
which superfluous or aged and damaged organelles are removed. 
It is also an important host defense mechanism that eliminates 
intracellular pathogens, as has been demonstrated for Legionella 
pneumophila and Acinetobacter baumannii (11, 12). However, 
some pathogens, such as Mycobacterium tuberculosis and Listeria 
monocytogenes, have evolved strategies to subvert autophagy 
for their own benefit (13, 14). The autophagy pathway can be a 
microorganism-friendly process that favors the intracellular sur-
vival of certain microorganisms. It exerts an anti-inflammatory 
effect through downregulation of the inflammasome, which pro-
motes the maturation of pro-inflammatory cytokines interleukin 
IL-1β and IL-18 (15, 16).
Monocytes/macrophages are part of the innate immune 
sys tem that provides the first line of defense against pathogens. 
Through phagocytosis and antigen presentation, they play impor-
tant roles in immune surveillance and immune regulation (17). 
Peri pheral monocytes tend to polarize to different subtypes of 
macrophages according to the tissue microenvironment. The Th1 
cytokine IFN-γ and TLR-4 agonist LPS polarize monocytes to 
the classical activated macrophages (M1 macrophages), which 
produce pro-inflammatory cytokines such as TNF-α and IL-12. 
M1 macrophages clear pathogens but also cause tissue damage. 
In contrast, upon exposure to Th2 cytokines such as IL-4, mono-
cytes differentiate into alternatively activated macrophages (M2 
macrophages) that produce anti-inflammatory mediators such 
as IL-10. M2 macrophages suppress inflammation and facilitate 
wound healing (18). The extent of tissue inflammation developed 
as a consequence of an innate immune response is determined in 
large part by the balance between the pro-inflammatory M1 and 
anti-inflammatory M2 macrophages (19). It was reported that 
Brucella infection prevents the apoptosis of monocyte and mac-
rophage and modulates macrophage functions (20–23). However, 
the effect of Brucella infection on macrophage polarization remains 
to be elucidated.
In this study, we investigated the effect of Brucella on periph-
eral monocytes and the polarization of macrophages. Our results 
indicated that infection with Brucella leads to an increase in 
CD14++CD16− monocytes and a decrease in CD14+CD16+ mono-
cytes, as well as an increase in the expression of the autophagy-
related protein LC3B in all monocyte subsets obtained from 
brucellosis patients. Brucella dysregulates monocytes and inhibits 
macrophage polarization through an upregulation of LC3-
dependent autophagy process.
MaTerials anD MeThODs
human blood samples
Diagnoses of acute brucellosis were made based on history, 
clinical presentation, and laboratory tests (1). Patients who had 
contact history with cattle, sheep, or deer and clinical manifesta-
tion of intermittent fever with or without arthralgia during the 
last 3 months were subjected to laboratory testing. Rose bengal 
test positive, serum agglutination titer >1:160, and PCR test 
[Diagnostic Kit for Brucella DNA Kit (Jiangsu Bioperfectus 
Technologies, Taizhou, China)] positive were confirmation of 
brucellosis. All the patients were also examined by chest tomog-
raphy and tuberculosis T-SPOT test to exclude tuberculosis. 
Twenty-five patients diagnosed with acute brucellosis and 
15 healthy individuals were included in this study (Table  1). 
All patients were treated with rifampicin and doxycycline for 
6 weeks, and five of them were recalled for posttreatment follow-
up and collection of blood samples. The demographic data and 
clinical characteristics before and after treatment are shown in 
Table  2. The venous blood from patients and healthy controls 
(HC) in terms of diagnosis were collected before and after treat-
ment. The study was approved by the Human Research Ethics 
Committee of the First Hospital of Jilin University, Jilin Province, 
Table 2 | The demographics and clinical characteristics of patients with 
brucellosis before and after treatment.
before treatment after treatment t-test
n 5
Male/female 3/2
Age (mean ± SD) 49 ± 11.34
Fever 100% 0%
Arthralgia 40% 0%
CRP (mean ± SD) 39.84 ± 17.24 3.86 ± 1.179 P < 0.01
ESR (mean ± SD) 35 ± 10.63 11.8 ± 2.538 P < 0.01
AST (mean ± SD) 33.80 ± 6.22 23.8 ± 3.68 ns
ALT (mean ± SD) 29.4 ± 2.19 21.6 ± 2.40 ns
PCR test 100% 0%
CNS, central nervous system; CRP, C-reactive protein; ESR, erythrocyte sedimentation 
rate; AST, aspartate aminotransferase; ALT, alanine aminotransferase; PCR, 
polymerase chain reaction. P values of <0.05 were considered statistically significant. 
ns, not significant.
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China. All adult subjects provided written informed consent, 
and no children were included in the study.
The Preparation of heat-Killed Brucella 
(hK-br)
The smooth strain B. abortus 2308 was grown overnight in tryptic 
soy broth, harvested by centrifugation, and washed twice in phos-
phate-buffered saline (PBS). Bacterial numbers in cultures were 
estimated by comparing the OD at 600 nm with a standard curve, 
but the actual concentration of inocula was checked by plating 
on tryptic soy agar (TSA) plates. All live Brucella manipula-
tions were performed in biosafety level 3 facilities (China CDC, 
Beijing). To prepare HK-Br, bacteria were washed in sterile PBS, 
heat killed at 70°C for 30 min, aliquoted, and stored at −70°C 
until used. The absence of B. abortus viability after heat killing 
was verified by the absence of bacterial growth on TSA.
cell isolation and Purification
PBMCs were isolated by density centrifugation using Lymphoprep 
(Fresenius Kabi Norge AS, Halden, Norway) as pre viously 
described (24). Monocytes were purified from PBMCs using 
a Human CD14 MicroBead Kit (Miltenyi Biotec, Bergisch 
Gladbach, Germany) as previously described (25). The purity of 
the CD14+ cells was >95% as determined by flow cytometry.
cell culture
Purified monocytes (2 × 106/ml) were stimulated with 1.0 µg/ml 
LPS from E. coli O111:B4 (Sigma-Aldrich Inc., St. Louis, MO, USA) 
as previously described (26, 27). Monocytes were differentiated to 
M1/M2 macrophages as previously described with modification 
(25). Briefly, purified monocytes (2 × 106/ml) were cultured with 
GM-CSF (400IU/ml) or M-CSF (50 ng/ml) for 5 days in RPMI 
1640 medium (Invitrogen, Carlsbad, CA, USA) supplemented 
with 10% heat-inactivated fetal calf serum, 100 IU/ml penicillin 
and 100  µg/ml streptomycin. For M1 polarization, GM-CSF-
induced macrophages were cultured with LPS (100  ng/ml) and 
IFN-γ (20  ng/ml) for an additional 24  h. For M2 polarization, 
M-CSF-induced macrophages were further cultured with IL-4 
(25 ng/ml) and IL-13 (25 ng/ml) for an additional 24 h. All the 
recombination human cytokines were purchased from R&D 
(Minneapolis, MN, USA).
To investigate the involvement of autophagy in monocytes and 
macrophage polarization, purified monocytes were pretreated 
with an autophagy inhibitor, 3  µM 3-MA (Sigma-Aldrich, 
St. Louis, MO, USA) for 3 h, and then cultured for 24 h with HK-Br 
(MOI =  100:1), 100  nM rapamycin (Sigma-Aldrich, St. Louis, 
MO, USA) was used as a positive control for autophagy as previ-
ous described (12).
Flow cytometry
Cell staining and flow cytometry analysis were performed as 
described (25). Briefly, differentiated M1 and M2 macrophages 
were characterized by staining with the following antibodies: 
mouse anti-human CD14-FITC, mouse anti-human CD16-
PE-Cy7, mouse anti-human CD80-PE, mouse anti-Human CD86-
FITC, mouse anti-human CD163-PE, and mouse anti-Human 
CD206-FITC. Markers of monocytes were mouse anti-human 
CD282-FITC, CD283-PE, and mouse anti-human CD284- 
APC. Mouse anti-human LC3B-PE was used as a marker for the 
autophagy-related protein (28). Intracellular staining was per-
formed using the following mouse anti-human mAb: TNF-α, IL-6, 
IL-1β, and IL-10. All the antibodies were purchased from BD 
Biosciences (San Jose, CA, USA), except for anti-LC3B antibody 
(Cell Signaling Technology, Danvers, MA, USA), and used at 
a dilution of 1:50. Flow cytometry was performed using a BD 
Biosciences FACS CANTOII flow cytometer (BD Biosciences). 
The data acquired were analyzed with FlowJo (Treestar software, 
Ashland, OR, USA).
Western blotting
Western blotting was performed according to the published 
method (9, 12). Samples (50 µg total protein/lane) were loaded 
onto SDS-PAGE gels in this experiment. The primary (rabbit 
anti-human LC3, rabbit anti-human Beclin-1 and rabbit anti-
human β-actin antibody) and secondary (anti-rabbit horseradish 
peroxidase-labeled antibody) antibodies were purchased from 
Cell Signaling Technology and used at a dilution of 1:1,000 and 
1:2,000, respectively. The images were obtained using a CanoScan 
LiDE 100 scanner (Canon). The results were quantified using 
Image-J software.
enzyme-linked immunosorbent assay 
(elisa)
Enzyme-linked immunosorbent assay was performed with 
human IL-1β, IL-6, IL-10, and TNF-α ELISA Ready-SET-Go Kits 
(eBioscience, San Diego, CA, USA) according to the manufac-
turer’s instructions.
statistical Methods
All data were analyzed using the D’Agostino and Pearson omnibus 
normality test. P values of <0.05 were considered statistically 
significant. Mean values were compared using either a paired 
t-test (two groups) or ANOVA (more than two groups), followed 
by a Bonferroni correction for multiple comparisons test. All 
FigUre 1 | Characteristics of monocyte subsets in patients with brucellosis and healthy control subjects. (a) Gating strategy for monocyte subsets. (b) The 
percentage of each monocyte subset in patients with Brucellia infection (BI) (n = 25) and healthy controls (HC) (n = 15). (c) The percentage of monocyte subsets in 
five brucellosis patients before and after a 6-week treatment with rifampicin and doxycycline. (D) The phenotypic comparisons of monocyte subsets were 
normalized as the ratio of brucellosis patients/HC. *P < 0.05. **P < 0.01; **P < 0.001.
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statistical tests were performed using GraphPad Prism software 
(San Diego, CA, USA).
resUlTs
Brucella infection increased the 
Proportion of cD14++cD16− Monocytes
Brucella establishes infection in host monocytes and mac-
rophages. To determine whether Brucella infection affects the 
frequency and phenotype of monocyte subsets, the monocytes 
were divided into three subsets based on CD14 and CD16 
expression (29) as gating strategy shown in Figure  1A. We 
observed that the proportion of CD14++CD16− monocytes in 
patients with Brucella infection was significantly higher than 
in HC, whereas the proportion of CD14+CD16+ monocytes 
was significantly lower. There was no significant difference in 
the CD14++CD16+ monocyte subset between the two groups 
(Figure 1B).
We further compared the frequency and phenotype of mono-
cyte subsets in five patients with brucellosis before and after treat-
ment with rifampicin and doxycycline. Results showed that the 
proportion of CD14++CD16− monocytes significantly decreased 
after 6  weeks of antibiotic treatment, whereas both CD14+ 
FigUre 2 | LC3B expression on monocytes of patients with brucellosis. LC3B expression levels on monocytes were analyzed by flow cytometry. LC3B expression 
levels detected in PBMCs by flow cytometry in 25 brucellosis patients and 15 healthy volunteers were included. The results were presented as the mean 
fluorescence intensity. (a) LC3B expression levels on monocytes from patients with Brucellia infection (BI) (n = 25) and healthy controls (HC) (n = 15). (b) LC3B 
expression levels on different monocyte subsets. (c,D) LC3B expression levels in monocytes were detected by flow cytometry using PBMCs from five patients 
before and after a 6-week treatment with rifampicin and doxycycline. (c) LC3B expression levels of monocytes from brucellosis patients (n = 5). (D) LC3B 
expression levels on different monocyte subsets. **P < 0.01; **P < 0.001.
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CD16+ and CD14++CD16+ monocytes increased significantly 
(Figure 1C).
To further characterize the phenotypic difference of mono-
cyte subsets between patients with Brucella infection and 
heal thy control individuals, cell surface expression of antigen 
presen ting markers: CD1a and CD1b, costimulatory molecules: 
CD40, CD80, and CD86, M2 macrophage markers: CD163 
and CD206, and TLR: CD282 (TLR-2), CD283 (TLR-3), and 
CD284 (TLR-4) were examined by flow cytometry. Results in 
Figure 1D showed that the expression levels of CD40, CD282, 
and CD284 on all three monocyte subsets are statistically higher 
in patients with Brucella infection than in healthy control indi-
viduals, whereas no significant differences were found in CD1a, 
CD1b, CD80, CD86, CD163, CD206, and CD283 expression 
levels for the various monocyte subsets between patients and 
controls.
Brucella-induced lc3-Dependent 
autophagy in Monocytes
Recent studies have shown that many human diseases result 
from overzealous innate immune responses including autophagy 
(30). Therefore, we investigated whether Brucella infection 
induces monocyte autophagy by quantify the expression of an 
autophagy-related protein LC3B using flow cytometry in patients 
with Brucella infection and in healthy control individuals. Results 
shown in Figure  2A demonstrated a higher LC3B expression 
level on the entire monocyte population from patients with 
Brucella infection than that from healthy control individuals, 
as well as monocyte subsets that are either CD14++CD16+ or 
CD14++CD16− (Figure 2B). It was reported that rifampicin inhib-
its rapamycin-induced autophagy (31). We further examined 
whether anti-Brucella treatment could modulate LC3B expression 
on monocytes. Figure 2C showed a significant downregulation 
FigUre 3 | Heat-killed Brucella (HK-Br) induced LC3-dependent autophagy. (a) Purified monocytes from five healthy volunteers were pretreated with rapamycin 
(100 nM, 12 h) or HK-Br (MOI = 100:1) for 24 h with or without 3-MA pretreatment (3 mM, 3 h), and the LC3B levels were detected by flow cytometry. (b) Western 
blotting of LC3 and Beclin-1 in pretreated cells were performed, and the ratios of LC3-II/LC3-I and Beclin-1/β-actin were calculated. *P < 0.05; **P < 0.01.
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of LC3B expression levels on the overall monocyte population 
after 6  weeks of treatment of brucellosis with rifampicin and 
doxycycline (P < 0.001), and the same is true for each of the three 
monocyte subsets (Figure 2D).
To determine whether Brucella infection induces LC3-dependent 
autophagy in monocytes, purified monocytes from healthy 
donors were cultured for 24 h with HK-Br (a possible autophagy 
inducer) in the presence or absence of 3-MA, and rapamycin was 
used as a positive control for autophagy (12). LC3B expression 
levels of monocytes were determined by flow cytometry. The 
results showed that both HK-Br and rapamycin significantly 
induced LC3B expression of monocytes compared with untreated 
monocytes, whereas 3-MA significantly inhibited HK-Br-induced 
LC3B expression (Figure 3A). Beclin-1 was regarded as an impor-
tant marker of autophagy as LC3 (12). Most autophagic respon-
ses were Beclin-1 dependent. The expression levels of LC3-I/II 
and Beclin-1 were also examined by western blotting, and β-actin 
was used as internal reference protein. The ratio of LC3-II/
LC3-1 and Beclin-1/β-actin were calculated. Consistently, both 
HK-Br and rapamycin increased the ratios of LC3-II/LC3-I and 
Beclin-1/β-actin, and 3-MA decreased these ratios (Figure 3B). 
Collectively, these results indicate that Brucella infection induces 
autophagy-related protein LC3B expression in monocytes.
Brucella infection inhibits the Function  
of Monocytes via autophagy
In response to pathogens, monocytes produce pro-inflammatory 
cytokines including IL-1β, IL-6, IL-8, and TNF-α, and 
anti-inflammatory cytokine such as IL-10 and TGF-β. To 
determine whether Brucella infection regulates monocyte func-
tion, purified monocytes from healthy donors and brucellosis 
patients were stimulated by LPS, with or without pretreatment 
with 3-MA. The expression and secretion of pro-inflammatory 
(IL-1β, IL-6, TNF-α) and anti-inflammatory (IL-10) cytokines 
were then examined by flow cytometry and by ELISA. Results 
in Figure 4 showed that upon LPS stimulation, monocytes from 
brucellosis patients expressed lower levels of TNF-α (Figure 4A), 
IL-6 (Figure  4B), IL-1β (Figure  4C), and IL-10 (Figure  4D) 
than those from HC. Conversely, 3-MA treatment that inhibited 
autophagy led to elevated expression of TNF-α (Figure  4E), 
IL-6 (Figure  4F), IL-1β (Figure  4G), and IL-10 (Figure  4H) 
than those from untreated monocytes from brucellosis patients. 
These results indicated that cytokine expression and production 
from monocytes is impaired after Brucella infection, but partially 
restored by the autophagy inhibitor.
Brucella infection inhibits Macrophage 
Polarization via autophagy
To further test whether Brucella infection alters monocyte 
polarization to M1/M2 macrophages, isolated monocytes were 
polarized to M1 and M2 macrophages in the presence or absence 
of 3-MA, and analyzed by flow cytometry. Results in Figure  5 
showed that M1 and M2 macrophages polarization was pheno-
typically different between monocytes obtained from patients 
with Brucella and those from healthy individuals. As expected, 
the polarization to M1/M2 macrophages in the presence of 
FigUre 4 | Brucella infection inhibited the function of monocytes via autophagy. Purified monocytes from 10 patients with Brucellia infection (BI) and 10 healthy 
controls (HC) were stimulated with lipopolysaccharide (LPS) (1 µg/ml, 6 h). (a) TNF-α, (c) IL-6, (e) IL-1β, and (g) IL-10 expression levels on monocytes and their 
production by monocytes were examined by intracellular cytokines staining and enzyme-linked immunosorbent assay (ELISA), respectively. Purified monocytes from 
six brucellosis patients were pretreated with 3-MA (3 mM, 3 h), and then stimulated with LPS. (b) TNF-α, (D) IL-6, (F) IL-1β, and (h) IL-10 expression levels on 
monocytes and their production by monocytes were examined by intracellular cytokines staining and ELISA, respectively. *P < 0.05, **P < 0.01, ***P < 0.001.
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3-MA was similar irrespective of the source of monocytes. 
Morphologically, M1 macrophages polarized from healthy indi-
viduals had a round-shaped appearance, while M2 macrophages 
exhibited a long spindle shape. In contrast, M1 macrophages 
polarized from patients with Brucella infection had a smaller 
round-shaped appearance, and M2 macrophages lacked the 
long spindle shape (Figure  5A). CD80 and CD86 were highly 
expressed on M1 macrophages, while CD163 and CD206 were 
highly expressed on M2 macrophages in healthy individuals. 
However, there were no obvious differences in CD80 and CD86 
expression levels between M1 and M2 macrophages in patients 
with Brucella infection. Additionally, CD80 and CD86 expression 
levels of M1 macrophages in patients with Brucella infection were 
significantly lower than those of healthy individuals (Figure 5B). 
In addition, the expression levels CD163 and CD206 on M2 
macrophages were higher than on M1 macrophages in patients 
with Brucella infection (Figure  5B). CD163 expression level 
on M2 macrophages in patients with Brucella infection was 
significantly lower than those of healthy control individuals, but 
CD206 expression level on M2 macrophages exhibited no such a 
difference. Moreover, 3-MA restored CD80 and CD86 expression 
levels on M1 macrophages, and CD163 and CD206 expression 
levels on M2 macrophages in brucellosis patients (Figure 5C).
The production of TNF-α and IL-10 are reflective of the 
pro-inflammatory and anti-inflammatory functions of M1 and 
M2 macrophages, respectively. Their production by M1 and 
M2 macrophages was quantified by ELISA and summarized in 
Figures 5D,E. As expected, M1 macrophages produced TNF-α 
and M2 macrophages secreted IL-10 in healthy control individu-
als. However, there were no obvious differences in TNF-α and 
IL-10 secretion by M1 and M2 macrophages in patients with 
Brucella infection, and their respective levels were both lower 
FigUre 5 | Brucella infection inhibited macrophage polarization via autophagy. Monocytes were purified from the peripheral blood of 10 patients with Brucellia 
infection (BI) and 10 healthy controls (HC), and purified monocytes from 6 patients with BI were also pretreated with 3-MA. These monocytes were polarized to M1 
and M2 macrophages. (a) Morphology was assessed by microscopy (scale bar 20 µm). (b) CD80, CD86, CD163, and CD206 expression of M1 and M2 
macrophages from brucellosis patients and healthy volunteers were analyzed by flow cytometry. (c) CD80 and CD86 expression of M1 macrophages, CD163 and 
CD206 expression of M2 macrophages were determined by flow cytometry. (D) TNF-α and (e) IL-10 production were detected by enzyme-linked immunosorbent 
assay. *P < 0.05, **P < 0.01, ***P < 0.001.
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than those in healthy individuals (Figure 5D). However, 3-MA 
treatment restored TNF-α production by M1 macrophages 
and IL-10 secretion by M2 macrophages in brucellosis patients 
(Figure 5E).
Taken together, these results indicate that the potential of 
monocytes to polarize into M1 or M2 macrophages is impaired 
in brucellosis patients, and it was recovered by 3-MA treatment.
The impairment of Macrophage 
Polarization in Patients with  
brucellosis is associated with  
Brucella-induced autophagy
To determine whether Brucella-induced autophagy of monocytes 
plays a role in macrophage polarization, purified monocytes 
from HC were pretreated for 24 h with HK-Br. Rapamycin and 
3-MA were also used as a positive control for autophagy, and 
an autophagy inhibitor, respectively. The pretreated monocytes 
were then polarized to M1/M2 macrophages as described 
above. M1 macrophages polarized from rapamycin-pretreated 
monocytes had a round-shaped appearance similar to those 
that received no pretreatment, while M2 macrophages from 
rapamycin-pretreated monocytes exhibited a smaller spindle-
like shape. Interestingly, both M1 and M2 macrophages polar-
ized from HK-Br-pretreated monocytes exhibited a smaller 
round shape. However, 3-MA treatment restored the morphol-
ogy of M2 macrophage, but not M1 macrophage (Figure 6A). 
The expression levels of CD80 and CD86 on M1 macrophages 
(Figures  6B,C) and TNF-α production (Figure  6F) from M1 
macrophages polarized from rapamycin-pretreated monocytes 
were similar to the controls; however, CD163 expression 
and IL-10 production of M2 macrophages polarized from 
FigUre 6 | Brucella infection impaired the polarization of monocytes to M1 and M2 macrophages in vitro. Pure monocytes from five healthy volunteers were 
pretreated with 100 nM rapamycin or heat-killed Brucella (HK-Br) (MOI = 100:1) for 24 h in presence or absence of 3-MA-pretreatment, and then monocytes were 
differentiated to M1 or M2 macrophages. (a) Their morphology was observed by microscopy (scale bar 20 µm). (b) CD80 and (c) CD86 expression of M1 
macrophages, (D) CD163 and (e) CD206 expression of M2 macrophages were determined by flow cytometry. (F) TNF-α production of M1 macrophages,  
(g) IL-10 production of M2 macrophages in the supernatants were examined by enzyme-linked immunosorbent assay. *P < 0.05, **P < 0.01, ***P < 0.001.
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rapamycin-pretreated monocytes were much lower than those 
with no pretreatment. CD86 expression on M1 macrophages 
and CD163 expression on M2 macrophages polarized from 
HK-Br-pretreated monocytes were significantly lower than 
those that received no pretreatment. Additionally, 3-MA treat-
ment partially relieves the HK-Br-mediated downregulation 
of CD163 expression (Figure  6D) on M2 macrophages, but 
not CD206 expression (Figure 6E). TNF-α production by M1 
macrophages and IL-10 production by M2 macrophages polar-
ized from HK-Br-pretreated monocytes were much lower than 
those without pretreatment. The HK-Br-mediated inhibition 
of IL-10 production by M2 macrophages was recovered with 
3-MA treatment (Figure 6G). Collectively, these results suggest 
that Brucella-induced autophagy affected the polarization of M2 
macrophages, but not M1 macrophages.
DiscUssiOn
Three subsets of monocytes have been identified with distinct 
phenotype: CD14++CD16− subset (classical subset), CD14+CD16+ 
subset (non-classical subset), and CD14++CD16+ subset (interme-
diate subset) (32). Changes in the proportions of these monocyte 
subsets in blood have been observed in many disorders (33). In 
the present study, we found that the proportion of CD14++CD16− 
monocytes in patients with brucellosis was significantly higher 
than in HC, whereas the proportion of CD14+CD16+ monocytes 
was significantly lower. In agreement with our findings, it has 
been reported that the proportion of CD14++CD16+ monocytes 
increases markedly in acute inflammation, and it could be 
regarded as a predictive marker for infection (34). CD14++CD16+ 
monocytes show a higher phagocytosis rate and secrete higher 
levels of IL-1β and TNF-α compared with the classical monocyte 
subset (CD14++CD16−) (35). However, the proportion of CD16+ 
intermediate monocytes decreases in some chronic inflammatory 
diseases, and the non-classical subset increases when infections 
have been established (36). We also found that the expression 
of TLR-2 (CD282) and TLR-4 (CD284) on all three monocyte 
subsets, particularly on the CD14++CD16− monocyte subset, 
increased in brucellosis patients compared with HC. TLR-2 
was reported to be activated by the L-outer membrane protein 
(OMP)16 and L-OMP19 of Brucella, and TLR-4 was activated by 
LPS and U-OMP16 (6). These results suggest that the expansion 
of the CD14++CD16− monocyte subset is specific to Brucella 
infection; Brucella may manipulate monocytes via TLRs.
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Autophagy is a cellular degradation process that captures and 
eliminates intracellular proteins and aged organelles by deliver-
ing them to lysosomes. This process helps cells to maintain 
a metabolic balance (37). We found that the expression level 
of an autophagy marker LC3B on monocytes in patients with 
brucellosis was higher than in HC, and its level decreased after 
6  weeks of treatment with rifampicin and doxycycline, which 
are recommended as the first-line antibiotics for human brucel-
losis by the World Health Organization. These results indicate 
that Brucella infection induces the upregulation of LC3B on 
CD14++CD16+ monocyte subset. Furthermore, we found that 
Brucella infection inhibited the production of pro-inflammatory 
and anti-inflammatory cytokines by monocytes stimulated by 
LPS, and such inhibition was relieved by an inhibitor of LC3B-
related autophagy, 3-MA. Therefore, our data confirm that 
Brucella induce LC3-related autophagy. Recent studies showed 
that autophagy plays a modulatory role in microbial infection. 
Some pathogens induce complete autophagic response and then 
died from it, whereas some other pathogens draw benefit from 
an incomplete autophagic response, which enable their survival 
and proliferation (30). Previous in  vitro studies have demon-
strated that autophagy facilitates Brucella survival (38), through 
unknown mechanisms. LC3 has been regarded as a major marker 
of autophagy; however, the role of LC3-related autophagy in 
Brucella infection remains controversial. Some studies reported 
that LC3 does not participate in the autophagy induced by 
Brucella infection (9). but other studies demonstrated that the 
Brucella-induced autophagic response is LC3-related (38).
Circulating monocytes can differentiate into macrophages, 
which can be classified into classically activated macrophages 
(M1) and alternatively activated macrophages (M2) (39). M1 
macrophages promote type 1 immune responses through the syn-
thesis of pro-inflammatory cytokines and chemokines, such as 
TNF-α, IL-1β, IL-12, IL-18, CCL15, CCL20, CXCL8-11, and 
CXCL13 (40). M2 macrophages participate in type 2 immune 
responses (41). M1/M2 polarization of macrophages in inflam-
mation and its resolution has been described for some diseases 
(19), but not for Brucella infection. We found that the potential of 
monocytes to polarize into M1 or M2 macrophages was impaired 
in brucellosis patients, and the impairments were reversed by 
inhibiting LC3B-related autophagy. To our knowledge, this is 
the first description of macrophage polarization in brucellosis 
patients. These results suggest that Brucella infection suppresses 
monocyte differentiation to both M1 and M2 macrophages 
by inducing LC3B-related autophagy.
Our results are in agreement with other studies reporting 
that autophagy influences the polarization of macrophages and 
down-regulates inflammation. Defects in macrophage autophagy 
may promote inflammatory disease. For instance, a decrease in 
macrophage autophagy in obesity leads to hepatic inflammation 
and the progression of liver injury (42), and specific proteins 
could induce autophagy and facilitate M2-type polarization 
of tumor-associated macrophages (43). We found that HK-Br 
and rapamycin upregulate LC3B expression on monocytes. 
Rapamycin only suppresses monocyte polarization to M2 mac-
rophages, and HK-Br inhibits monocyte polarization to both 
M1 and M2 macrophages. Rapamycin is a macrocyclic triene 
antibiotic, now considered an immunosuppressive agent for the 
prevention of kidney transplant rejection (44), and an autophagy 
inducer that is often used as a positive control for autophagic 
response. Rapamycin can induce LC3-dependent autophagy in 
macrophages and epithelial cells (45). Recently, it was also shown 
that rapamycin affects M2 survival and diminishes the M1-like 
inflammatory responses in patients with type I diabetes (46). 
Therefore, our results are consistent with the idea that Brucella 
inhibits M2 macrophage polarization by inducing LC3B-related 
autophagy. The specific mechanisms by which Brucella infection 
inhibits M1 macrophage polarization remain unknown.
In summary, we found that Brucella infection led to an increase 
in the proportion of CD14++CD16− monocytes, a decrease in the 
proportion of CD14+CD16+ monocytes, and increased expres-
sion of the autophagy-related protein LC3B in CD14++CD16−  
monocytes obtained from brucellosis patients. In addition, 
Brucella infection inhibited the production of pro-inflammatory 
and anti-inflammatory cytokines by monocytes via LC3-
dependent autophagy. Moreover, Brucella infection inhibited 
macrophage polarization, and 3-MA, an inhibitor of LC3B-
related autophagy, partially restored macrophage polarization 
in patients with brucellosis. Intriguingly, we also found that 
the upregulation of LC3B expression by rapamycin and HK-Br 
in  vitro inhibited M2 macrophage polarization, and 3-MA 
partially restored the macrophage polarization. Taken together, 
these findings reveal that Brucella dysregulates monocyte and 
macrophage polarization through LC3B-dependent autophagy. 
Immune modulation through this pathway may lead to the 
development of new therapeutics. Brucellosis is caused by 
several species from Brucella genre, but we have no evidence 
to conclude that the findings in this study extends for different 
Brucella species, a relation between the bacterial pathogenicity 
and its effect on LC3-induced autophagy needs to be further 
explored as well in the future.
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